Pharmaceuticals(33)

  • Modulating Weight Gain and Loss by Understanding the Mechanism of Smoking Related Weight Changes (No. T4-2078)

    Of the approximately 30 million adult smokers in the U.S, more than half report attempting to quit smoking every year. However, smoking cessation-associated weight gain (SCWG) constitutes a major obstacle to smoking withdrawal. ... Read more
    Associate Professor Eran Elinav

    Eran Elinav

    Faculty of Biology

    17357
  • Treatment for Ewing Sarcoma Using ETS Proteins (No. T4-2068)

    Ewing sarcoma (ES) is a common bone malignancy in children and young adolescents which is usually treated by systemic chemotherapy. In about 25% of the cases, cancer has already spread to other parts of the body at the time of diagnosis. ... Read more
    Extension Service Yosef Yarden

    Yosef Yarden

    Faculty of Biology

    6154
  • Increasing Immunotherapy Efficacy of Anti PD-L1 (No. T4-2059)

    Immunotherapy has revolutionized cancer treatment by activating the immune system to attack tumor cells. However, notable limitations remain, including differential responses between individuals and cancer types. Dr. ... Read more
    Prof Rony Dahan

    Rony Dahan

    Faculty of Biology

    17039
  • Peptides for Treating Alzheimer's Disease (No. T4-2057)

    Alzheimer's Disease (AD) is an age-associated neurodegenerative disorder characterized clinically by a decline in cognitive function. It is the most common type of dementia, with 5.8 million Americans living with AS in 2020. ... Read more
    Full Professor Ruth Arnon

    Ruth Arnon

    Faculty of Biology

    6160
  • Safer CAR-T Cell Platform (No. T4-2033)

    Chimeric Antigen Receptor (CAR)-T Cell Therapy is a personalized treatment for cancer in which the patient's T cells are genetically engineered to express a synthetic receptor that binds a tumor antigen. ... Read more
    Associate Professor Sarel FLEISHMAN

    Sarel-Jacob Fleishman

    Faculty of Biochemistry

    6124
  • Biologic Drug for Prevention and Treatment of COVID-19 (No. T4-2024)

    Combat against COVID-19 is still ongoing worldwide. ... Read more
    Full Professor Gideon Schreiber

    Gideon Schreiber

    Faculty of Biochemistry

    Full Professor Yinon Rudich

    Yinon Rudich

    Faculty of Chemistry

    6027
  • Small Molecules for Treatment of Huntington's Disease and Related Disorders (No. T4-1947)

    Trinucleotide repeats expansion disorders (TREDs) are a set of diseases in which repetitions of short DNA segments (three nucleotides) occur and accumulate in the genome. ... Read more
    Full Professor Rivka Dikstein

    Rivka Dikstein

    Faculty of Biochemistry

    6193
  • New Antiviral Drugs from Bacterial Natural Products (No. T4-1934)

    The increasing incidence of viral infections across the globe is driving the demand for antiviral drugs. Prof. Rotem Sorek and his team identified a new family of bacterial enzymes that produce various nucleotide analogs with antiviral properties (Bernheim, Nature 2021). ... Read more
    Full Professor Rotem Sorek

    Rotem Sorek

    Faculty of Biochemistry

    12514
  • Higher Efficiency of CRISPR Gene Editing Using Chimeric Cas9 (No. T4-1930)

    CRISPR-Cas9 is a powerful tool for genome editing, widely used for basic research and the development of treatments for genetic diseases. However, its efficiency is currently limited. ... Read more
    Emeritus Yosef Shaul

    Yosef Shaul

    Faculty of Biochemistry

    6024
  • Protein Based Treatment for Duchene Muscular Dystrophy and Cancer (No. T4-1913)

    Duchenne muscular dystrophy (DMD) is a disease that affects approximately 1 in 3,500 boys with a life expectancy of ~26 years. ... Read more
    Full Professor Irit Sagi

    Irit Sagi

    Faculty of Biology

    6026

Pages

Subscribe to Pharmaceuticals